Arexvy was ~82% effective in preventing RSV-induced lower respiratory tract infections in adults aged 60 or more years.
FDA approves first pill for fecal transplant therapy
Apr 27, 2023
Vowst is approved to prevent recurrence of C. difficile/ The pill contains live gut bacteria from stool samples donated by healthy people.
Sleep problems linked to increased risk for stroke
Apr 06, 2023
The odds of stroke increased with short or long duration of sleep, impaired sleep quality, snoring, snorting and breathing cessation.
US sets up $300 million database for Alzheimer’s disease research
Apr 05, 2023
In creating the database, the goal is to provide something that can “improve applicability and generalizability of findings.”
Novo Nordisk to cut insulin prices by up to 75 percent
Mar 14, 2023
The news follows a similar move made by Eli Lilly, which said earlier this month that it will cut insulin prices by 70%.
Breakthrough SARS-CoV-2 similar for chronic liver disease with, without cirrhosis
Mar 07, 2023
However, full vaccination was associated with two-thirds lower risk for death with cirrhosis.
FDA panel backs Pfizer RSV vaccine for older Americans
Mar 01, 2023
Pfizer has reported that its vaccine would reduce risk from RSV by as much as 86%.
Allogeneic stem cell transplant feasible for leukemia in elderly patients
Feb 21, 2023
Overall survival was 64% and 55% at one and two years, respectively; nonrelapse mortality was 20 and 28%, respectively
Persistent gaps exist in continuity of medication use for adults with diabetes
Jan 30, 2023
A mean of 19.5, 17.1 and 43.3% of participants did not maintain continuity of use of glucose, blood pressure or lipid medications.
FDA approves new two-drug combo medicine for asthma
Jan 12, 2023
The medication is the first approved in the United States to contain an inhaled corticosteroid as a reliever rather than as a controller of asthma symptoms.